Danske Bank’s West Pharmaceutical WST Stock Holding History

Danske Bank’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.83M	Sell	31,248 -2,269	-7%	-$565K	0.02%	476
2025 Q4	$9.22M	Buy	33,517 +1,654	+5%	+$452K	0.02%	454
2025 Q3	$8.36M	Buy	31,863 +1,754	+6%	+$426K	0.02%	461
2025 Q2	$6.59M	Buy	30,109 +2,076	+7%	+$444K	0.02%	497
2025 Q1	$6.28M	Sell	28,033 -7,718	-22%	-$2.13M	0.02%	496
2024 Q4	$11.7M	Buy	35,751 +4,227	+13%	+$1.33M	0.04%	384
2024 Q3	$9.46M	Buy	31,524 +2,781	+10%	+$852K	0.03%	400
2024 Q2	$9.47M	Sell	28,743 -1,951	-6%	-$689K	0.03%	381
2024 Q1	$12.1M	Buy	+30,694	New	+$11.4M	0.04%	382

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Danske Bank's WST Position: Q1 2026 in Review

Danske Bank reduced its West Pharmaceutical (WST) stake by 6.8% in Q1 2026, selling an estimated $565K and leaving 31,248 shares worth $7.83M. The position accounts for 0.02% of the portfolio, ranked #476.

Danske Bank first reported a position in WST in Q1 2024 and has held it in 9 quarters since. The position peaked at $12.1M in Q1 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

Danske Bank held 31,248 shares of West Pharmaceutical worth $7.83M as of Q1 2026.
Danske Bank sold 2,269 West Pharmaceutical shares in Q1 2026, an estimated $565K.
West Pharmaceutical made up 0.02% of Danske Bank's portfolio in Q1 2026, its #476 holding.
Danske Bank first reported a position in West Pharmaceutical in Q1 2024 and has held it in 9 quarters since.
Danske Bank's West Pharmaceutical position peaked at $12.1M in Q1 2024.
753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.